HGF and neoplasm: Two recent reports show that both IL-6-Stat3 and HGF-Met oncogenic signaling pathways are negatively regulated by miR-26a in HCCs, suggesting that downregulation of miR-26a promotes proliferation, migration and invasion of tumor cells in vitro and in vivo [25, 26].